Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Luzu® (luliconazole) – Expanded indication
February 20, 2018 - The FDA approved Valeant’s Luzu (luliconazole) cream, for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum.
